IL135210A0 - Metalloproteinase inhibitors - Google Patents
Metalloproteinase inhibitorsInfo
- Publication number
- IL135210A0 IL135210A0 IL13521097A IL13521097A IL135210A0 IL 135210 A0 IL135210 A0 IL 135210A0 IL 13521097 A IL13521097 A IL 13521097A IL 13521097 A IL13521097 A IL 13521097A IL 135210 A0 IL135210 A0 IL 135210A0
- Authority
- IL
- Israel
- Prior art keywords
- methoxysuccinamide
- pyridin
- isobutyl
- propyl
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB1997/003132 WO1999025693A1 (en) | 1997-11-13 | 1997-11-13 | Metalloproteinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL135210A0 true IL135210A0 (en) | 2001-05-20 |
Family
ID=10807699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13521097A IL135210A0 (en) | 1997-11-13 | 1997-11-13 | Metalloproteinase inhibitors |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1030842B1 (de) |
JP (1) | JP2001523666A (de) |
KR (1) | KR100485479B1 (de) |
AT (1) | ATE236126T1 (de) |
AU (1) | AU740420B2 (de) |
BR (1) | BR9714934A (de) |
CA (1) | CA2310593C (de) |
DE (1) | DE69720554T2 (de) |
DK (1) | DK1030842T3 (de) |
ES (1) | ES2195122T3 (de) |
GB (1) | GB2333524A (de) |
HU (1) | HUP0002811A3 (de) |
IL (1) | IL135210A0 (de) |
NO (1) | NO315702B1 (de) |
NZ (1) | NZ503642A (de) |
PL (1) | PL189542B1 (de) |
PT (1) | PT1030842E (de) |
RU (1) | RU2198164C2 (de) |
TR (1) | TR200001353T2 (de) |
TW (1) | TW474919B (de) |
WO (1) | WO1999025693A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9506535A (pt) * | 1994-01-20 | 1997-09-16 | British Biotech Pharm | Inibidores de metaloproteinases |
WO1997003966A1 (en) * | 1995-07-19 | 1997-02-06 | British Biotech Pharmaceuticals Limited | N-(amino acid) substituted succinic acid amide derivatives as metalloproteinase inhibitors |
-
1997
- 1997-11-13 HU HU0002811A patent/HUP0002811A3/hu unknown
- 1997-11-13 GB GB9816317A patent/GB2333524A/en not_active Withdrawn
- 1997-11-13 PL PL97340494A patent/PL189542B1/pl not_active IP Right Cessation
- 1997-11-13 TR TR2000/01353T patent/TR200001353T2/xx unknown
- 1997-11-13 BR BR9714934-9A patent/BR9714934A/pt not_active Application Discontinuation
- 1997-11-13 RU RU2000114634/04A patent/RU2198164C2/ru not_active IP Right Cessation
- 1997-11-13 DK DK97912351T patent/DK1030842T3/da active
- 1997-11-13 EP EP97912351A patent/EP1030842B1/de not_active Expired - Lifetime
- 1997-11-13 AT AT97912351T patent/ATE236126T1/de not_active IP Right Cessation
- 1997-11-13 WO PCT/GB1997/003132 patent/WO1999025693A1/en not_active Application Discontinuation
- 1997-11-13 NZ NZ503642A patent/NZ503642A/en unknown
- 1997-11-13 KR KR10-2000-7004964A patent/KR100485479B1/ko not_active IP Right Cessation
- 1997-11-13 CA CA002310593A patent/CA2310593C/en not_active Expired - Fee Related
- 1997-11-13 JP JP2000521077A patent/JP2001523666A/ja not_active Withdrawn
- 1997-11-13 ES ES97912351T patent/ES2195122T3/es not_active Expired - Lifetime
- 1997-11-13 PT PT97912351T patent/PT1030842E/pt unknown
- 1997-11-13 AU AU49584/97A patent/AU740420B2/en not_active Ceased
- 1997-11-13 DE DE69720554T patent/DE69720554T2/de not_active Expired - Fee Related
- 1997-11-13 IL IL13521097A patent/IL135210A0/xx not_active IP Right Cessation
- 1997-12-02 TW TW086118078A patent/TW474919B/zh not_active IP Right Cessation
-
2000
- 2000-05-12 NO NO20002480A patent/NO315702B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU4958497A (en) | 1999-06-07 |
NO20002480L (no) | 2000-05-12 |
NZ503642A (en) | 2001-10-26 |
NO315702B1 (no) | 2003-10-13 |
PL189542B1 (pl) | 2005-08-31 |
GB2333524A (en) | 1999-07-28 |
HUP0002811A2 (hu) | 2001-01-29 |
JP2001523666A (ja) | 2001-11-27 |
ATE236126T1 (de) | 2003-04-15 |
DE69720554T2 (de) | 2004-01-08 |
EP1030842B1 (de) | 2003-04-02 |
NO20002480D0 (no) | 2000-05-12 |
WO1999025693A1 (en) | 1999-05-27 |
TW474919B (en) | 2002-02-01 |
TR200001353T2 (tr) | 2000-10-23 |
BR9714934A (pt) | 2000-10-03 |
EP1030842A1 (de) | 2000-08-30 |
HUP0002811A3 (en) | 2002-11-28 |
KR20010031879A (ko) | 2001-04-16 |
KR100485479B1 (ko) | 2005-04-27 |
DE69720554D1 (de) | 2003-05-08 |
ES2195122T3 (es) | 2003-12-01 |
CA2310593A1 (en) | 1999-05-27 |
RU2198164C2 (ru) | 2003-02-10 |
DK1030842T3 (da) | 2003-07-28 |
PL340494A1 (en) | 2001-02-12 |
PT1030842E (pt) | 2003-07-31 |
CA2310593C (en) | 2007-05-08 |
AU740420B2 (en) | 2001-11-01 |
GB9816317D0 (en) | 1998-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITMI921601A1 (it) | Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci. | |
NZ501277A (en) | -2(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors | |
AR012172A2 (es) | Composiciones farmaceuticas que comprenden analogos de lactacistina y uso de los mismos para la fabricacion de un medicamento | |
GEP20033117B (en) | Hydroxy Pipecolate Hydroxamic Acid Derivatives as MMP Inhibitors, Pharmaceutical Compositions Containing Them and Their Use for Treatment of Diseases caused by MMP | |
TR200101969T2 (tr) | Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları. | |
TR200001846T2 (tr) | İştah bastırıcı aktiviteye sahip farmasötik kompozisyonlar | |
DE69827236D1 (en) | Matrix-metalloproteinase-hemmer | |
ATE116657T1 (de) | 7-keto- und 7-hydroxy-androsta-3,5-dien-3- carbonsäure derivate. | |
NZ301645A (en) | (R)-(-)-methyl phenyl oxazolidinone derivatives, pharmaceutical preparations and use for treating TNF stimulated diseases | |
EP0627442A4 (de) | Methode und vorrichtung zur reinigung oder kühlung von gas. | |
RU94044454A (ru) | Ингибитор аутоимунных заболеваний | |
ES2156120T3 (es) | Derivados arilamidicos. | |
RU94037246A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования разрушения хряща | |
ES2060578T3 (es) | Sintesis de compuestos tipo podofilotoxina. | |
NZ504084A (en) | Processes for producing 7-isoindolinequinolonecarboxylic derivatives and its intermediates, as well as salts of 7-isoindolinequinolonecarboxylic acid derivatives, its hydrates and composition comprising the same as active ingredient | |
RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
IL135210A0 (en) | Metalloproteinase inhibitors | |
Tandon et al. | Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol | |
AU5516590A (en) | Dehydrocholecalciferol derivatives | |
ITPD920145A1 (it) | Uso terapeutico della fosforil-l-serina-n-acil-sfingosina | |
AU640647B2 (en) | 3-butenamide derivatives | |
EA200400096A1 (ru) | Применение корриноидов при кожных заболеваниях | |
DE69414396T2 (de) | Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten | |
BR9906975A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processo para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero | |
ES550781A0 (es) | Un procedimiento para preparar un derivado de 1-benzhidril--4-cinamilpiperazina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |